Add BrightSurf on Google Email

Science News Archive 2002 - Page 72


Page 72 of 93

Treating metastatic disease with a modified herpesvirus

Researchers have successfully treated metastatic disease using a modified herpesvirus, providing a promising treatment option for patients with advanced cancer. The therapy has shown promise in early trials, demonstrating its potential as a novel approach to combatting this devastating disease.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 27, 2002

Effect of diet on risk of benign prostate disease in middle-aged men

A study of 33,344 participants found that higher dietary energy intake was associated with a greater risk of benign prostate disease. Additionally, high protein intake, especially from animal sources, and certain polyunsaturated fats increased the risk. The authors suggest that dietary factors may contribute to the development of BPH.

SourceAmerican Journal of Clinical Nutrition·JournalAmerican Journal of Clinical Nutrition·DateMar 25, 2002

Traits link viruses from common cold to HIV

Scientists found that viruses causing diverse ailments like AIDS, common cold, and hepatitis share functional traits, linking large groups of viruses. These traits involve replication mechanisms and messenger RNA stages, suggesting a common ancestor among the viruses. The discovery bolsters prospects for broad-spectrum antiviral agents.

SourceUniversity of Wisconsin-Madison·JournalMolecular Cell·DateMar 25, 2002

Genomics and public health

The University of Michigan has launched a new Center for Genomics and Public Health, which aims to narrow the gap between genomics and public health practice. The center will examine population-based data to describe genes associated with cardiovascular disease and understand their interaction with other risk factors.

Bone loss resumes when hormone replacement therapy stops, but at normal rate

A long-term follow-up study of over 800 postmenopausal women found that stopping hormone replacement therapy resumes bone loss at a rate similar to those who never took the drugs. The study showed that while bone mass increased in the first 36 months after starting hormone replacement therapy, there was little gain after that.

SourceAtrium Health Wake Forest Baptist·JournalArchives of Internal Medicine·DateMar 24, 2002

Free web-based tool makes map colors a snap

ColorBrewer is a free web-based tool that enables users to select from various color schemes for their maps. The tool offers sequential, diverging, and qualitative schemes, allowing users to test and refine their choices. Additionally, ColorBrewer provides detailed color specifications for printing, projection, or web display.

Students more afraid to attend school after Columbine

A study by the Center for Disease Control and Prevention found that students were significantly less likely to report considering suicide after the Columbine incident, but the incidence of attempts remained unchanged. The fear of unsafe schools varied depending on location, with urban teens showing a notable increase in safety concerns.

SourceCenter for Advancing Health·JournalAmerican Journal of Preventive Medicine·DateMar 22, 2002